The Nutshell

» funding, genetics & genomics and NIH

Daily News Roundup

Most Recent

image: PubMed-Indexed Abstracts to Include COI Statements

PubMed-Indexed Abstracts to Include COI Statements

By | April 19, 2017

Expressions of concern will also be linked in study summaries. 

0 Comments

image: Oklahoma De-funds Science Fair

Oklahoma De-funds Science Fair

By | April 12, 2017

Students launch a fundraising campaign to rescue the event, which was a casualty of budget cuts to the state’s education department. 

2 Comments

image: Report: Boost Funds for Basic Science in Canada

Report: Boost Funds for Basic Science in Canada

By | April 12, 2017

An independent review of Canadian science reveals a need for additional funds to investigator-led, basic research.

0 Comments

Scientists identify a mutation in the CRY1 gene in people with abnormal sleeping patterns.

0 Comments

23andMe customers can now receive information about genetic risk for diseases including Parkinson’s and celiac.

0 Comments

image: Trump Meets with HHS, NIH Brass

Trump Meets with HHS, NIH Brass

By | April 5, 2017

President Donald Trump, HHS Secretary Tom Price, and NIH Director Francis Collins discussed the opioid crisis and retaining young researchers in the biomedical research enterprise, among other things, according to a White House official.

0 Comments

Both Democrats and Republications criticize the Trump administration’s plan to cut funding for biomedical research.

0 Comments

image: Drastic Cuts to Brazil’s Federal Science Budget

Drastic Cuts to Brazil’s Federal Science Budget

By | April 4, 2017

The 44 percent drop in funding is disproportionately large compared to overall reductions in government spending.

0 Comments

image: Mutations Linked to Secondary Cancers

Mutations Linked to Secondary Cancers

By | April 4, 2017

Childhood cancer survivors with mutations in certain cancer-risk genes have a higher risk of developing additional neoplasms later in life, according to research presented at the American Association for Cancer Research annual meeting.

0 Comments

At the annual American Association for Cancer Research meeting, researchers discuss the importance of understanding the epigenetic contributors to cancer progression and treatment response.

0 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS